• EN/ES

    Orthopedics

    WebHealthNetwork : 2,378,479


  • Benefits & Savings

  • : Erythema

Erythema - 159 Studies Found

Terminated : Safety Study of AMG 811 in Subjects With Discoid Lupus Erythematosus
:
  • Cutaneous Lupus
  • Discoid Lupus
  • : 2010-07-15
    :
    • Drug: AMG811 Twelve subjects w

Active, not recruiting : Autologous Polyclonal Tregs for Lupus
:
  • Lupus Erythematosus, Cutaneous
  • Lupus Erythematosus, Discoid : 2015-04-23
    : Biological: Ex vivo Expanded Human Autologous Polyclonal Regulatory T Cells Other Name: Ex vivo Expanded
Completed : Pilot Tape Harvesting Study
:
  • Atopic Dermatitis
  • Healthy
  • Discoid Lu
    : 2014-04-25
    :
    • Procedure: Skin Taping Skin ta

Completed : Phase Ib Study of SC Milatuzumab in SLE
:
  • Lupus Erythematosus, Cutaneous
  • Lupus Erythematosus, Discoid : 2013-04-17
    :
    • Drug: milatuzumab Milatuzumab

Active, not recruiting : A Phase 2a, Efficacy and Safety Study of Ustekinumab in Systemic Lupus Erythematosus
: Lupus Erythematosus, Systemic
: 2015-01-23
:
  • Drug: Ustekinumab IV Weight-ra

Terminated : Pharmacokinetics Study of Epratuzumab in Systemic Lupus Erythematosus (SLE)
: Lupus Erythematosus, Systemic
: 2005-06-10
: Drug: epratuzumab
Not yet recruiting : Effect of Qi Gong Training on Quality of Life in Patients With Systemic Lupus Erythematous (LuQi)
: Lupus Erythematosus, Systemic
: 2016-03-29
: Other: Qi Gong The aim of this study is to evaluate the effects of Qi Gong on quality if life in patient
Not yet recruiting : Allogeneic Blood Stem Cell Transplantation for Patients With Life-Threatening Systemic Lupus Erythematosus
: Lupus Erythematosus, Systemic
: 2006-05-12
: Procedure: Hematopoietic Cell Transplantation 1200 cGy total lymphoid irradiation (TLI) are administered
Completed : Anti-CD20 in Systemic Lupus Erythematosus
: Lupus Erythematosus, Systemic
: 2002-05-10
: Drug: Rituximab Subjects received four weekly infusions of rituximab at a dose of 375 mg/m^2
Not yet recruiting : A Study to Evaluate the Efficacy and Safety of CC-220 in Subjects With Active Systemic Lupus Erythematosus
: Lupus Erythematosus, Systemic
: 2017-05-18
:
  • Drug: CC-220 0.45 mg QD PO

<<< Previous | Next >>>
Orthopedics Health
Orthopedics Health WebHealth Network Media
  • WebHealthNetwork
  • DiabetesHealthMatters
  • HeartandStrokeHealth
  • WomensHealthCareCommunity
  • AsthmaHealthCenter
  • CancerHealthCenter
  • MentalHealthHelpCenter
  • Skincarehealthcenter
  • DigestiveTractHealth
  • VaccineHealthCenter
  • PainHealthCenter
  • FightingAddictionCenter
  • ObesityHealthMatters
  • SeniorHealthcareMatters
  • BrainAndNerveCenter
  • PediatricsHealthCenter
  • RareDiseasesHealthCenter
  • Wealth Mason
  • Home Owners Circle
  • EasyInsuranceFinder
  • EduJumpStart
  • SaleSpider
  • ScoopCafe
  • SaleSpiderMedia
  • Viewpoint.World
  • TravelerBooked
  • TechNewsBytes
  • Contact Us
  • Advertising Privacy Policy

This site uses cookies for analytics and advertising. No personal information is collected.

© Orthopedics Health .

We use cookies to enhance your experience, analyze anonymized traffic, and deliver personalized content and ads. No personal information is collected. By using our website, you consent to our use of cookies and agree to our data practices as described in our Privacy Policy. To Reject, please change your browser settings.